Drug Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name PHI-101
Trade Name
Synonyms PHI101|PHI 101
Drug Descriptions

PHI-101 is a Chk2 inhibitor (Cancer Res 2021;81(13_Suppl):Abstract nr 1461) with additional activity against FLT3 (Cancer Res 2020;80(16 Suppl):Abstract nr 4226), which potentially results in antitumor activity (Cancer Res 2021;81(13_Suppl):Abstract nr 1461, Cancer Res 2020;80(16 Suppl):Abstract nr 4226).

DrugClasses CHK2 Inhibitor 7 FLT3 Inhibitor 64
CAS Registry Number 2127107-15-5
NCIT ID C179279


  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")


  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
Olaparib + PHI-101 Olaparib PHI-101 0 0
PHI-101 PHI-101 9 0

Additional content available in CKB BOOST